| Primary |
| Urinary Tract Infection |
25.0% |
| Product Used For Unknown Indication |
18.3% |
| Cellulitis |
7.2% |
| Hypertension |
6.4% |
| Premature Rupture Of Membranes |
6.2% |
| Drug Use For Unknown Indication |
5.7% |
| Infection |
4.9% |
| Lower Respiratory Tract Infection |
4.7% |
| Localised Infection |
2.5% |
| Pulmonary Embolism |
2.3% |
| Atrial Fibrillation |
2.1% |
| Bacterial Infection |
2.1% |
| Diabetes Mellitus |
1.9% |
| Prophylaxis |
1.9% |
| Upper Respiratory Tract Infection |
1.7% |
| Infection Prophylaxis |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Urethritis |
1.5% |
| Bronchitis |
1.3% |
| Schizophrenia |
1.3% |
|
| Urticaria |
16.1% |
| Vomiting |
15.7% |
| Rash |
12.6% |
| White Blood Cell Count Increased |
5.4% |
| Drug Exposure During Pregnancy |
4.9% |
| Somnolence |
4.0% |
| Diarrhoea |
3.6% |
| Treatment Failure |
3.6% |
| Acute Generalised Exanthematous Pustulosis |
3.1% |
| Anaphylactic Reaction |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Rash Pruritic |
3.1% |
| Swelling |
3.1% |
| Clostridial Infection |
2.7% |
| Drug Ineffective |
2.7% |
| Rash Generalised |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Urinary Tract Infection |
2.7% |
| Weight Decreased |
2.7% |
| Angioedema |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
38.3% |
| Drug Use For Unknown Indication |
18.0% |
| Urinary Tract Infection |
9.7% |
| Hypertension |
5.5% |
| Foetal Exposure During Pregnancy |
5.4% |
| Infection |
2.7% |
| Migraine |
2.3% |
| Suicide Attempt |
2.2% |
| Pulmonary Embolism |
1.9% |
| Pain |
1.9% |
| Cellulitis |
1.8% |
| Prophylaxis |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Bipolar Disorder |
1.2% |
| Depression |
1.2% |
| Sinusitis |
1.2% |
| Urethritis |
1.2% |
| Atrial Fibrillation |
0.9% |
| Crohn's Disease |
0.9% |
| Anxiety |
0.9% |
|
| White Blood Cell Count Increased |
15.9% |
| Drug Hypersensitivity |
13.6% |
| Myalgia |
6.8% |
| Urticaria |
6.3% |
| Completed Suicide |
5.7% |
| Sepsis |
5.1% |
| Vomiting |
5.1% |
| Rash |
4.5% |
| Nausea |
4.0% |
| Vestibular Disorder |
4.0% |
| Poisoning |
3.4% |
| Rhabdomyolysis |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Urinary Tract Infection |
3.4% |
| Drug Toxicity |
2.8% |
| Erectile Dysfunction |
2.8% |
| Stevens-johnson Syndrome |
2.8% |
| Death |
2.3% |
| Liver Function Test Abnormal |
2.3% |
| Urine Output Decreased |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.4% |
| Product Used For Unknown Indication |
19.4% |
| Pain |
8.1% |
| Depression |
6.4% |
| Hypertension |
5.3% |
| Contraception |
4.1% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Anxiety |
3.2% |
| Rheumatoid Arthritis |
2.9% |
| Acne |
2.6% |
| Prophylaxis |
2.5% |
| Premenstrual Syndrome |
2.3% |
| Urinary Tract Infection |
2.3% |
| Breast Cancer |
2.2% |
| Multiple Myeloma |
2.1% |
| Metastases To Bone |
2.1% |
| Asthma |
2.0% |
| Insomnia |
1.9% |
| Arthritis |
1.8% |
| Nausea |
1.8% |
|
| Weight Decreased |
15.7% |
| Vomiting |
14.1% |
| Pulmonary Embolism |
10.0% |
| Weight Increased |
7.1% |
| Pain |
6.4% |
| Urinary Tract Infection |
6.3% |
| Deep Vein Thrombosis |
4.9% |
| Type 2 Diabetes Mellitus |
4.5% |
| Wheezing |
3.6% |
| Pneumonia |
2.7% |
| Tooth Extraction |
2.7% |
| Tremor |
2.7% |
| Injury |
2.6% |
| Nausea |
2.6% |
| Anxiety |
2.4% |
| Pain In Extremity |
2.4% |
| Thrombosis |
2.3% |
| Vision Blurred |
2.3% |
| Visual Disturbance |
2.3% |
| White Blood Cell Count Increased |
2.3% |
|
| Interacting |
| Urinary Tract Infection |
40.0% |
| Pulmonary Embolism |
13.3% |
| Hypersensitivity |
6.7% |
| Migraine |
6.7% |
| Acne |
3.3% |
| Hypertension |
3.3% |
| Infection |
3.3% |
| Nasopharyngitis |
3.3% |
| Onychomycosis |
3.3% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Sleep Disorder |
3.3% |
| Smoking Cessation Therapy |
3.3% |
|
| Drug Interaction |
18.2% |
| Vomiting |
18.2% |
| Hypoglycaemia |
9.1% |
| Increased Appetite |
9.1% |
| Pain |
9.1% |
| Retroperitoneal Haematoma |
9.1% |
| Skin Exfoliation |
9.1% |
| Urinary Tract Infection |
9.1% |
| White Blood Cell Count Increased |
9.1% |
|
